Join us as we extend our felicitations to Dr. Nyanyiwe Masingi Mbeye, Principal Investigator for the Global Evidence, Local Adaptation (GELA) project and Senior Lecturer in the School of Global and Public Health at the Kamuzu University of Health Sciences (KUHeS) for getting an award of a prestigious Low and Middle Income Countries Stipend to attend the Cochrane Colloquium from 4-6 September 2023 at the Queen Elizabeth II (QEII) Centre in London.

Under the theme ‘Forward together for trusted evidence,’ the colloquium aims to explore the challenges for the future around trustworthiness of healthcare data and information. Dr Nyanyiwe will be making an oral presentation on Global Evidence, Local Adaptation (GELA): Enhancing evidence-informed guideline recommendations for newborn and young
child health in three countries in sub-Saharan Africa.

Nyanyiwe is currently the country Principal Investigator for the GELA project which is a three year European and Developing Countries Clinical Trials Partnership (EDCTP) funded project that aims to enhance evidence-informed guideline recommendations for newborn and young child health in South Africa, Malawi and Nigeria. It aims to maximize the impact of evidence for Poverty-Related Diseases (PRDs) by increasing the capacity of decision makers and researchers to use global research to develop locally relevant guidelines for newborn and child health.

The project is led by Cochrane South Africa, South African Medical Research Council and will build on and add value to the large-scale program of child-health guideline development led by the World Health Organization (WHO), with adaptation and implementation led by the WHO Afro Regional Office, country offices and national ministries.

GELA Partners include the Norwegian Institute of Public Health, the Norwegian University of Science and Technology, Western Norway University of Applied Science, Stellenbosch University (South Africa), the University of Calabar Teaching Hospital (Nigeria), Kamuzu University of Health Sciences (Malawi), Cochrane and the Stiftelsen MAGIC Evidence Ecosystem (Norway).

For More about GELA kindly follow this link: